Healthy mom, healthy baby. The concept sounds simple enough, but a recent Northwestern Medicine study found the level of health literacy—how someone obtains, uses and understands health information—among pregnant people isn’t where it needs to be, and it’s having a negative impact on babies in utero and after birth, especially among people of color. Of
Gene therapy for spinal muscular atrophy might have a high up-front price tag. But by screening and treating infants early, the therapy can save both lives and money in the long term. Spinal muscular atrophy (SMA), a type of motor neurone disease, is one of the deadliest genetic illnesses an infant can be diagnosed with.
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down’s syndrome. Despite children with Down’s syndrome having around a one in 50 chance of developing acute myeloid leukaemia (AML), compared to a one
Children who are born severely ill or who develop serious illness in the first few weeks of life are often difficult to diagnose, with considerable implications for their short and longer-term care. Whole genome sequencing carried out quickly has the potential to provide an early diagnosis, and thus improve the clinical care of these infants
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok